Munafa Stock Market Course + Intraday & FNO calls 
Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Array Biopharma (ARRY)
Technical Analysis Report for USA stock ARRY Array Biopharma. Dated: 31 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma then click here. or read Experts views on Array Biopharma or Forecast & share price targets of Array Biopharma
Array Biopharma Opened at 4.55 and Closed at: 4.42, which is -3.85% of previous session's close. It moved within a range of 4.38 and 4.57
The session was a Bearish session with an average volume of 6844800, which is 3.91% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 4.31 and resistance for tomorrow is 4.5
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 4.34, 4.27 resistance for tomorrow's hourly charts is 4.53, 4.65
10 Day SMA for Array Biopharma (ARRY) is 4.66 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Array Biopharma (ARRY) is 5.01 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Array Biopharma (ARRY) is 5.78 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 6.96 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Array Biopharma is 7.92 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Array Biopharma is at 5.01 and 200 DMA is at 7.92, while 50 DMA and 100 DMA are at 5.78 and 6.96 respectively
Array Biopharma (ARRY) moving average of 20 SMA is at 5.01 and 20 EMA is at 4.95
| Date | Closing Price | 20 SMA | 20 EMA |
| 31 Mon Aug | 4.42 | 5.01 | 4.95 |
| 28 Fri Aug | 4.59 | 5.07 | 5.01 |
| 27 Thu Aug | 4.67 | 5.1 | 5.05 |
| 26 Wed Aug | 4.71 | 5.12 | 5.09 |
| 25 Tue Aug | 4.55 | 5.13 | 5.13 |
| 24 Mon Aug | 4.57 | 5.15 | 5.19 |
Array Biopharma (ARRY) moving average of 50 SMA is at 5.78 and 50 EMA is at 5.7
| Date | Closing Price | 50 SMA | 50 EMA |
| 31 Mon Aug | 4.42 | 5.78 | 5.7 |
| 28 Fri Aug | 4.59 | 5.86 | 5.75 |
| 27 Thu Aug | 4.67 | 5.93 | 5.8 |
| 26 Wed Aug | 4.71 | 5.99 | 5.85 |
| 25 Tue Aug | 4.55 | 6.05 | 5.9 |
| 24 Mon Aug | 4.57 | 6.12 | 5.96 |
Array Biopharma (ARRY) moving average of 100 SMA is at 6.96 and 100 EMA is at 6.57
| Date | Closing Price | 100 SMA | 100 EMA |
| 31 Mon Aug | 4.42 | 6.96 | 6.57 |
| 28 Fri Aug | 4.59 | 6.98 | 6.61 |
| 27 Thu Aug | 4.67 | 7.01 | 6.65 |
| 26 Wed Aug | 4.71 | 7.04 | 6.69 |
| 25 Tue Aug | 4.55 | 7.06 | 6.73 |
| 24 Mon Aug | 4.57 | 7.08 | 6.77 |
Array Biopharma (ARRY) moving average of 200 SMA is at 7.92 and 200 EMA is at 7.16
| Date | Closing Price | 200 SMA | 200 EMA |
| 31 Mon Aug | 4.42 | 7.92 | 7.16 |
| 28 Fri Aug | 4.59 | 7.94 | 7.19 |
| 27 Thu Aug | 4.67 | 7.96 | 7.22 |
| 26 Wed Aug | 4.71 | 7.98 | 7.25 |
| 25 Tue Aug | 4.55 | 8 | 7.28 |
| 24 Mon Aug | 4.57 | 8.02 | 7.31 |
Arcus Biosciences has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Arcus Biosciences, about 28% more returns!
Perrigo Company has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Perrigo Company, about 62.14% more returns!
Penumbra Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Penumbra Inc, about 25.98% more returns!
Baxter International has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Baxter International, about 18.04% more returns!
Trupanion Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Trupanion Inc, about 44.59% more returns!
Sol Gel has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Sol Gel, about 8.11% more returns!
Prothena Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Prothena Corporation, about 36.46% more returns!
Petmed Express has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Petmed Express, about 21.3% more returns!
Phibro Animal has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Phibro Animal, about 29.47% more returns!
Lipocine Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Lipocine Inc, about 31.49% more returns!
Immuron has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Immuron, about 29.11% more returns!
Immutep has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Immutep, about 21.2% more returns!
Immucell Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Immucell Corporation, about 14.77% more returns!
Gossamer Bio has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Gossamer Bio, about 20.77% more returns!
Genesis Healthcare has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Genesis Healthcare, about 35.99% more returns!
Editas Medicine has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Editas Medicine, about 36.8% more returns!
Cocrystal Pharma has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Cocrystal Pharma, about 44.7% more returns!
Chemocentryx Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Chemocentryx Inc, about 13.16% more returns!
Acadia Pharmaceuticals has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Acadia Pharmaceuticals, about 32.81% more returns!
Array Biopharma Technical analysis of indicators
Price action analysis of Array Biopharma (ARRY) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
Array Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Array Biopharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.64 and Array Biopharma ARRY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Array Biopharma ARRY stock. Volume based technical analysis of Array Biopharma ARRY stock is negative.
Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ARRY Experts View which covers a lot of information including buying and selling signals
ARRY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Array Biopharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
